Many of Australia's top brokers have been busy adjusting their financial models again, leading to the release of a number of broker notes this week.
Three ASX shares brokers have named as buys this week are listed below. Here's why they are bullish on them:
Goodman Group (ASX: GMG)
According to a note out of Citi, its analysts have retained their buy rating and $24.50 price target on this industrial property company's shares. This follows the release of a first-quarter update which highlighted continued strong operational results. Looking ahead, the broker believes the company is well-positioned due to tight supply and its large development pipeline. The Goodman share price is trading at $22.33 today.
ResMed Inc. (ASX: RMD)
A note out of Macquarie reveals that its analysts have retained their outperform rating on this sleep treatment company's shares with an improved price target of $33.40. The broker has been looking at the healthcare sector and its research suggests that ResMed's return on equity can improve more than most in the sector in the coming years. It also doesn't believe the Ozempic selloff has been justified. The ResMed share price is fetching $23.83 on Wednesday.
Treasury Wine Estates Ltd (ASX: TWE)
Analysts at Morgans have retained their add rating and lifted their price target on this wine giant's shares to $14.15. This follows news that the company has agreed to acquire the Paso Robles luxury wine business, DAOU Vineyards, for US$900 million (A$1.4 billion). Morgans is a fan of the deal and has upgraded its earnings estimates to reflect it. And with the company's shares trading at a big discount to historical multiples, it feels now is the time to buy. The Treasury Wine share price is trading at $11.47 this afternoon.
